A detailed history of Bridgeway Capital Management, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 85,600 shares of PSNL stock, worth $441,696. This represents 0.01% of its overall portfolio holdings.

Number of Shares
85,600
Previous 135,600 36.87%
Holding current value
$441,696
Previous $158,000 191.14%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $6.34 $59,500 - $317,000
-50,000 Reduced 36.87%
85,600 $460,000
Q1 2024

May 15, 2024

BUY
$1.15 - $2.19 $7,014 - $13,359
6,100 Added 4.71%
135,600 $202,000
Q4 2023

Feb 14, 2024

SELL
$0.93 - $2.35 $23,250 - $58,750
-25,000 Reduced 16.18%
129,500 $271,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $3.19 $70,200 - $124,410
39,000 Added 33.77%
154,500 $290,000
Q3 2022

Nov 14, 2022

BUY
$2.89 - $5.32 $333,795 - $614,460
115,500 New
115,500 $343,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $237M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.